Real-world effectiveness and safety of simnotrelvir/ritonavir for COVID-19: A nationwide, multicenter, prospective, observational cohort study in China.
Han B, Du C, Deng M, Tang R, Dong J, Song X, Qiao Y, Ni Z, Yang W, Yang J, Xiang T, Huang Y, Zhong Y, Zhang Z, Yang L, Yang J, Wang J, Zheng L, Ma L, Shou Z, Cao R, Ma J, He G, Yuan J, Pang C, Xu J, Huang J, Yuan X, Wu Y, Xiong Y, Zhang X, Liu H, Gao B, Chen H, Ma T, Dang S, Zhang Q, Yuan R, Wei Y, Xu T, Deng Z, Gong Y, Gao J, Jiang R.
Han B, et al.
J Infect. 2024 Nov 7;89(6):106339. doi: 10.1016/j.jinf.2024.106339. Online ahead of print.
J Infect. 2024.
PMID: 39521253
Free article.